Bennicas & Associates’s PIMCO Enhanced Short Maturity Active Exchange-Traded Fund MINT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.88M Sell
19,075
-2,125
-10% -$210K 1.09% 29
2022
Q3
$2.1M Sell
21,200
-300
-1% -$29.7K 1.34% 23
2022
Q2
$2.13M Hold
21,500
1.24% 24
2022
Q1
$2.15M Hold
21,500
1.08% 31
2021
Q4
$2.18M Hold
21,500
1.14% 31
2021
Q3
$2.19M Sell
21,500
-800
-4% -$81.6K 1.23% 26
2021
Q2
$2.27M Hold
22,300
1.25% 23
2021
Q1
$2.27M Hold
22,300
1.3% 22
2020
Q4
$2.27M Hold
22,300
1.33% 20
2020
Q3
$2.27M Buy
+22,300
New +$2.27M 1.41% 20
2013
Q3
Sell
-9,600
Closed -$972K 87
2013
Q2
$972K Buy
+9,600
New +$975K 0.67% 55

Other funds holding MINT

Bennicas & Associates's MINT Position: Q4 2022 in Review

Bennicas & Associates reduced its PIMCO Enhanced Short Maturity Active Exchange-Traded Fund (MINT) stake by 10% in Q4 2022, selling an estimated $210K and leaving 19,075 shares worth $1.88M. The position accounts for 1.09% of the portfolio, ranked #29.

Bennicas & Associates first reported a position in MINT in Q2 2013 and has held it in 11 quarters since. The position peaked at $2.27M in Q4 2020. 641 funds tracked by Wall St. Rank hold MINT as of Q4 2022.

  • Bennicas & Associates held 19,075 shares of PIMCO Enhanced Short Maturity Active Exchange-Traded Fund worth $1.88M as of Q4 2022.
  • Bennicas & Associates sold 2,125 PIMCO Enhanced Short Maturity Active Exchange-Traded Fund shares in Q4 2022, an estimated $210K.
  • PIMCO Enhanced Short Maturity Active Exchange-Traded Fund made up 1.09% of Bennicas & Associates's portfolio in Q4 2022, its #29 holding.
  • Bennicas & Associates first reported a position in PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q2 2013 and has held it in 11 quarters since.
  • Bennicas & Associates's PIMCO Enhanced Short Maturity Active Exchange-Traded Fund position peaked at $2.27M in Q4 2020.
  • 641 funds tracked by Wall St. Rank held PIMCO Enhanced Short Maturity Active Exchange-Traded Fund as of Q4 2022.

Based on Bennicas & Associates's 13F filing for Q4 2022, filed 12 Jan 2023.